次世代シークエンシング（NGS）の世界市場予測（～2021）...市場調査レポートについてご紹介

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary (Page No. – 32)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 36)
4.1 Global NGS Market (2016–2021)
4.2 Global NGS Market Share, By Products & Services (2016 vs 2021)
4.3 NGS Sequencing Services Market, By Applications (2016 vs 2021)
4.4 Global NGS Technology Market Size, By Region (2016-2021)

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Products & Services
5.2.2 By Technology
5.2.3 By Application
5.2.4 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Technological Advancements in Sequencing Platforms
5.3.1.2 Increasing Applications of NGS
5.3.1.3 Growing Partnerships and Collaborations
5.3.1.4 Research Laboratories and Academicians Promoting NGS
5.3.1.5 Entry of New Market Players
5.3.1.6 Conferences and Workshops Increasing Awareness on NGS Products and Services
5.3.2 Restraints
5.3.2.1 Accuracy & Standardization Concerns in Diagnostic Testing
5.3.2.2 Lack of Skilled Professionals
5.3.2.3 Ethical and Legal Issues Related to NGS
5.3.3 Opportunities
5.3.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of Next Generation Sequencing Market
5.3.3.2 Emerging Markets Offer Numerous Growth Opportunities
5.3.3.3 Cloud Computing, A Prospective Service
5.3.4 Challenges
5.3.4.1 Interpretation of Complex Data From NGS Platforms
5.3.4.2 Storage of Sequencing Data
5.3.5 Current Trends
5.3.5.1 Development of New and Advanced NGS Platforms
5.3.5.2 Focus on Cancer Research
5.3.5.3 Mergers and Acquisitions

6 Global Next Generation Sequencing Market, By Products & Services (Page No. – 55)
6.1 Introduction
6.2 Pre-Sequencing Products & Services
6.2.1 Sample Preparation
6.2.1.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection
6.2.1.2 Library Preparation & Target Enrichment
6.2.1.3 Quality Control
6.3 NGS Platforms, Consumables, & Services for Platforms
6.3.1 NGS Platforms Market
6.3.1.1 Illumina
6.3.1.1.1 Hiseq Series
6.3.1.1.2 Hiseq X Ten & Hiseq X Five
6.3.1.1.3 Miseq Series
6.3.1.1.4 Nextseq500
6.3.1.2 Thermo Fisher Scientific (Life Technologies)
6.3.1.2.1 Solid Series
6.3.1.2.2 ION Torrent Platforms
6.3.1.2.2.1 ION PGM
6.3.1.2.2.2 ION Proton
6.3.1.2.2.3 ION S5 & S5 Xl
6.3.1.3 Pacific Biosciences
6.3.1.3.1 Pacbio Rs Ii
6.3.1.3.2 Sequel System
6.3.1.4 Recently Launched Sequencing Platforms
6.4 Sequencing Services
6.4.1 Targeted Re-Sequencing
6.4.2 RNA-Seq
6.4.3 De Novo Sequencing
6.4.4 Exome Sequencing
6.4.5 Chip-Seq
6.4.6 Whole-Genome Sequencing
6.4.7 Methyl-Seq
6.4.8 Others
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Global Next-Generation Sequencing Market, By Technology (Page No. – 85)
7.1 Introduction
7.2 Sequencing By Synthesis (SBS)
7.3 ION Semiconductor Sequencing
7.4 Sequencing By Ligation (SBL)
7.5 Pyrosequencing
7.6 Single-Molecule Real-Time Sequencing (SMRT)
7.7 Other Technologies

8 Global Next Generation Sequencing Market, By Application (Page No. – 93)
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery
8.4 Biomarker Discovery
8.5 Personalized Medicine
8.6 Agriculture & Animal Research
8.7 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. – 102)
9.1 Introduction
9.1.1 Research Centers and Academic & Government Institutes
9.1.2 Hospitals & Clinics
9.1.3 Pharmaceutical & Biotechnology Companies
9.1.4 Other End-Users (NPO, Agrigenomics Organizations, Consumer Genomic Companies)

10 Next Generation Sequencing Market, By Region (Page No. – 108)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Favorable Government Funding Scenario in the U.S. Market
10.2.1.2 Growing Focus of Next Generation Sequencing Market Players on Strengthening Their Presence in the U.S.
10.2.1.3 Increasing Number of Next Generation Sequencing Conferences in the U.S.
10.2.1.4 Increasing Focus of Laboratories to Obtain Clia Certification
10.2.2 Canada
10.2.2.1 Favorable Government Funding Scenario in Canada
10.2.2.2 Growing Focus of Market Players on Expanding Their Presence in Canada
10.3 Europe
10.3.1 Market Players Capitalizing on Opportunities in the European Next Generation Sequencing Market
10.3.1.1 Launch of New and Advanced Products and Services
10.3.1.2 Strategic Partnerships/Agreements/Collaborations to Develop Advanced Techniques
10.3.2 Germany, U.K., and Belgium: Major Hubs for Scientific Research
10.3.3 Growing Funding and Investments for NGS in Europe
10.4 Asia-Pacific
10.4.1 Growing Focus of Domestic and Multinational Players on APAC Market
10.4.1.1 Launch of Advanced NGS Products and Services
10.4.1.2 Partnerships/Collaborations/Agreements to Co-Develop Advanced NGS Products and Services
10.4.2 Favorable Government Funding Scenario in Several Asia-Pacific Countries
10.4.3 Growth in the Number of Conferences/Seminars/Training Programs in the Asia-Pacific Region
10.5 Rest of the World (RoW)
10.5.1 Focus of Key Market Players on Expanding Their Presence in the Rest of The World Region
10.5.2 Growing Number of Workshops and Conferences
10.5.3 Implementation of Favorable Initiatives By Public and Private Organizations

11 Competitive Landscape (Page No. – 141)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches and Product Enhancements
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.4 Geographic Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 149)
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Illumina, Inc.
12.3 Thermo Fisher Scientific, Inc.
12.4 Pacific Biosciences of California, Inc.
12.5 Beijing Genomics Institute
12.6 Qiagen N.V.
12.7 454 Life Sciences Corporation (Roche Holding AG)
12.8 Agilent Technologies, Inc.
12.9 Eurofins Scientific
12.10 Gatc Biotech AG
12.11 Macrogen Inc.
12.12 Oxford Nanopore Technologies, Ltd.
12.13 Perkinelmer, Inc.

13 Appendix (Page No. – 202)
13.1 Discussion Guide*
13.2 Introducing RT: Real-Time Market Intelligence
13.3 Available Customizations
13.4 Related Reports